Literature DB >> 9155026

Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation.

B Morgan1, L Sun, N Avitahl, K Andrikopoulos, T Ikeda, E Gonzales, P Wu, S Neben, K Georgopoulos.   

Abstract

Development of the lymphoid system is dependent on the activity of zinc finger transcription factors encoded by the Ikaros gene. Differences between the phenotypes resulting from a dominant-negative and a null mutation in this gene suggest that Ikaros proteins act in concert with another factor with which they form heterodimers. Here we report the cloning of Aiolos, a gene which encodes an Ikaros homologue that heterodimerizes with Ikaros proteins. In contrast to Ikaros--which is expressed from the pluripotent stem cell to the mature lymphocyte--Aiolos is first detected in more committed progenitors with a lymphoid potential and is strongly up-regulated as these differentiate into pre-T and pre-B cell precursors. The expression patterns of Aiolos and Ikaros, the relative transcriptional activity of their homo- and heteromeric complexes, and the dominant interfering effect of mutant Ikaros isoforms on Aiolos activity all strongly suggest that Aiolos acts in concert with Ikaros during lymphocyte development. We therefore propose that increasing levels of Ikaros and Aiolos homo- and heteromeric complexes in differentiating lymphocytes are essential for normal progression to a mature and immunocompetent state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155026      PMCID: PMC1169803          DOI: 10.1093/emboj/16.8.2004

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  119 in total

1.  Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization.

Authors:  F Romero; C Martínez-A; J Camonis; A Rebollo
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

3.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

Authors:  J Koipally; A Renold; J Kim; K Georgopoulos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

4.  DNase I footprinting of the human interleukin-5 gene promoter.

Authors:  D J Cousins; D Richards; D M Kemeny; S Romagnani; T H Lee; D Z Staynov
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 5.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 6.  U2AF homology motifs: protein recognition in the RRM world.

Authors:  Clara L Kielkopf; Stephan Lücke; Michael R Green
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

7.  Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression.

Authors:  Shibin Ma; Simanta Pathak; Malay Mandal; Long Trinh; Marcus R Clark; Runqing Lu
Journal:  Mol Cell Biol       Date:  2010-06-21       Impact factor: 4.272

8.  Ikaros promotes early-born neuronal fates in the cerebral cortex.

Authors:  Jessica M Alsiö; Basile Tarchini; Michel Cayouette; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 9.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18

10.  Medicine. How thalidomide works against cancer.

Authors:  A Keith Stewart
Journal:  Science       Date:  2014-01-17       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.